Sanson M - Search Results

1

TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.

Nencha U, Rahimian A, Giry M, Sechi A, Mokhtari K, Polivka M, Schmitt Y, Di Stefano AL, Alentorn A, Labussière M, Sanson M. Nencha U, et al. Among authors: sanson m. J Neurooncol. 2016 Feb;126(3):441-6. doi: 10.1007/s11060-015-1999-3. Epub 2015 Nov 25. J Neurooncol. 2016. PMID: 26608520

2

Analysis of the p21 gene in gliomas.

Li YJ, Hoang-Xuan K, Zhou XP, Sanson M, Mokhtari K, Faillot T, Cornu P, Poisson M, Thomas G, Hamelin R. Li YJ, et al. Among authors: sanson m. J Neurooncol. 1998 Nov;40(2):107-11. doi: 10.1023/a:1006149021810. J Neurooncol. 1998. PMID: 9892092

3

Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.

Zhou XP, Li YJ, Hoang-Xuan K, Laurent-Puig P, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G, Hamelin R. Zhou XP, et al. Among authors: sanson m. Int J Cancer. 1999 Apr 20;84(2):150-4. doi: 10.1002/(sici)1097-0215(19990420)84:2<150::aid-ijc10>3.0.co;2-#. Int J Cancer. 1999. PMID: 10096247 Free article.

4

P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia.

He J, Hoang-Xuan K, Marie Y, Leuraud P, Mokhtari K, Kujas M, Delattre JY, Sanson M. He J, et al. Among authors: sanson m. Neurology. 2000 Sep 26;55(6):867-9. doi: 10.1212/wnl.55.6.867. Neurology. 2000. PMID: 10994011

5

Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.

Leuraud P, Marie Y, Robin E, Huguet S, He J, Mokhtari K, Cornu P, Hoang-Xuan K, Sanson M. Leuraud P, et al. Among authors: sanson m. J Neurooncol. 2000 Dec;50(3):207-13. doi: 10.1023/a:1006400723490. J Neurooncol. 2000. PMID: 11263500

6

Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study.

Sanson M, Napolitano M, Yaya R, Keime-Guibert F, Broët P, Hoang-Xuan K, Delattre JY. Sanson M, et al. J Neurooncol. 2000 Dec;50(3):245-9. doi: 10.1023/a:1006494032052. J Neurooncol. 2000. PMID: 11263504 Clinical Trial.

7

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P, Capelle L, Delattre JY, Poirier J, Hoang-Xuan K. He J, et al. Among authors: sanson m. J Neuropathol Exp Neurol. 2001 Sep;60(9):863-71. doi: 10.1093/jnen/60.9.863. J Neuropathol Exp Neurol. 2001. PMID: 11556543

8

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.

Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P, Capelle L, Delattre JY, Poirier J, Broët P, Sanson M. Hoang-Xuan K, et al. Among authors: sanson m. Neurology. 2001 Oct 9;57(7):1278-81. doi: 10.1212/wnl.57.7.1278. Neurology. 2001. PMID: 11591848

9

OLIG-1 and 2 gene expression and oligodendroglial tumours.

Hoang-Xuan K, Aguirre-Cruz L, Mokhtari K, Marie Y, Sanson M. Hoang-Xuan K, et al. Among authors: sanson m. Neuropathol Appl Neurobiol. 2002 Apr;28(2):89-94. doi: 10.1046/j.1365-2990.2002.00395.x. Neuropathol Appl Neurobiol. 2002. PMID: 11972795 Review.

10

Prognostic value of allelic losses and telomerase activity in meningiomas.

Leuraud P, Dezamis E, Aguirre-Cruz L, Taillibert S, Lejeune J, Robin E, Mokhtari K, Boch AL, Cornu P, Delattre JY, Sanson M. Leuraud P, et al. Among authors: sanson m. J Neurosurg. 2004 Feb;100(2):303-9. doi: 10.3171/jns.2004.100.2.0303. J Neurosurg. 2004. PMID: 15098535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page